BioSim considers that the INGESA specifications present some deficits in aspects that are "essential"

The Spanish Association of Biosimilars - BioSim has a negative assessment of the specifications of the Framework Agreement for the purchase of biosimilars published by the National Institute of Health Management (INGESA), although it also maintains open to dialogue to find a point that allows the process to continue.

READ MORE